Correlation Between Novo Nordisk and ProKidney Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ProKidney Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ProKidney Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and ProKidney Corp, you can compare the effects of market volatilities on Novo Nordisk and ProKidney Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ProKidney Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ProKidney Corp.

Diversification Opportunities for Novo Nordisk and ProKidney Corp

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novo and ProKidney is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ProKidney Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProKidney Corp and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ProKidney Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProKidney Corp has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ProKidney Corp go up and down completely randomly.

Pair Corralation between Novo Nordisk and ProKidney Corp

Assuming the 90 days horizon Novo Nordisk AS is expected to generate 0.7 times more return on investment than ProKidney Corp. However, Novo Nordisk AS is 1.44 times less risky than ProKidney Corp. It trades about -0.06 of its potential returns per unit of risk. ProKidney Corp is currently generating about -0.05 per unit of risk. If you would invest  10,659  in Novo Nordisk AS on November 27, 2024 and sell it today you would lose (1,603) from holding Novo Nordisk AS or give up 15.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  ProKidney Corp

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
ProKidney Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ProKidney Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Novo Nordisk and ProKidney Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and ProKidney Corp

The main advantage of trading using opposite Novo Nordisk and ProKidney Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ProKidney Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProKidney Corp will offset losses from the drop in ProKidney Corp's long position.
The idea behind Novo Nordisk AS and ProKidney Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device